FDA
-
-
-
-
-
-
-
Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD
-
-
-
-
-
-
-
Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research
-
-
-
-
-
-
-
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
-
-
-
-
-
-
-
Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform
-
-
-
-
-
-
-
Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event
-
-
-
-
-
-
-
Firefly Neuroscience (AIFF) Advances AI-Driven BNA Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and Novartis
-
-
-
-
-
-
-
Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th
-
322,240 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

